Danhui Zhang Selected Research

5- (6- (1- azabicyclo(2,2,2)oct- 3- yloxy)pyridazin- 3- yl)- 1H- indole

12/2015	α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage.
10/2014	The α7 nicotinic receptor agonist ABT-107 decreases L-Dopa-induced dyskinesias in parkinsonian monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Danhui Zhang Research Topics

Disease

14	Parkinson Disease (Parkinson's Disease) 01/2021 - 09/2006
10	Dyskinesias (Dyskinesia) 01/2017 - 09/2013
6	Parkinsonian Disorders (Parkinsonism) 01/2021 - 09/2013
3	Movement Disorders (Movement Disorder) 12/2016 - 10/2014
3	Tardive Dyskinesia 12/2016 - 10/2014
2	Neoplasms (Cancer) 10/2022 - 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022
1	Alzheimer Disease (Alzheimer's Disease) 12/2015
1	Ataxia (Dyssynergia) 10/2014
1	Mental Disorders (Mental Disorder) 10/2014
1	Tourette Syndrome (Tourette's Syndrome) 10/2014
1	Psychotic Disorders (Schizoaffective Disorder) 10/2014
1	Schizophrenia (Dementia Praecox) 10/2014
1	Nervous System Diseases (Neurological Disorders) 07/2011

Drug/Important Bio-Agent (IBA)

10	Levodopa (L Dopa)FDA LinkGeneric 01/2017 - 09/2013
6	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2015 - 10/2013
6	Nicotine FDA Link 12/2015 - 09/2013
5	Pharmaceutical PreparationsIBA 12/2016 - 10/2013
4	Cholinergic Agents (Cholinergics)IBA 12/2016 - 10/2014
3	Phosphotransferases (Kinase)IBA 01/2021 - 11/2006
3	Antipsychotic Agents (Antipsychotics)IBA 12/2016 - 10/2014
2	AntibodiesIBA 10/2022 - 01/2018
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021 - 09/2013
2	3- (5,6- dichloropyridin- 3- yl)- 3,6- diazabicyclo(3.2.0)heptaneIBA 12/2015 - 04/2014
2	5- (6- (1- azabicyclo(2,2,2)oct- 3- yloxy)pyridazin- 3- yl)- 1H- indoleIBA 12/2015 - 10/2014
2	Dopamine (Intropin)FDA LinkGeneric 01/2015 - 09/2006
2	Neuroprotective AgentsIBA 10/2014 - 09/2007
2	pozaniclineIBA 10/2014 - 04/2014
1	RibonucleoproteinsIBA 10/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	ABT-126IBA 12/2015
1	Carbidopa (Lodosyn)FDA LinkGeneric 12/2015
1	SmokeIBA 01/2015
1	Antidepressive Agents (Antidepressants)IBA 01/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015
1	Varenicline (Chantix)FDA Link 10/2014
1	Dihydroxyphenylalanine (Dopa)IBA 09/2013
1	ManganeseIBA 07/2011
1	Protein Isoforms (Isoforms)IBA 09/2007
1	rottlerinIBA 09/2007
1	Protein Kinase C-deltaIBA 09/2007
1	Protein Kinase CIBA 09/2007
1	Caspase 3 (Caspase-3)IBA 11/2006
1	Peptides (Polypeptides)IBA 11/2006
1	Protein Kinases (Protein Kinase)IBA 11/2006
1	Proteasome InhibitorsIBA 09/2006
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 09/2006
1	UbiquitinIBA 09/2006
1	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2006
1	Proteins (Proteins, Gene)FDA Link 09/2006

Therapy/Procedure

9	Therapeutics 10/2022 - 09/2013
1	Drug Therapy (Chemotherapy) 10/2022
1	Immunotherapy 10/2022